esmo 2017: h&n, cetuximab e cisplatino con o senza paclitaxel in 1° linea?
Published 7 years ago • 587 plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
4:58
esmo 2017: catia angiolini, il punto sui biosimilari
-
1:26
blu-222: a esmo 2022 prime evidenze sui cdk2
-
0:48
welcome to esmo18!
-
0:49
mucosectom -- for a safe therapeutic approach
-
0:45
tmcx medical device 2017 - elsius biomedical
-
8:13
mouth cancer #best treatment# response and survival#indian study from bengal#cetuximab f/b nivolumab
-
1:56
cems - cardiologia - centro medico specialistico verona
-
6:24
epatocarcinoma, una overview da esmo 2021
-
5:41
pembrolizumab vs cetuximab with radiotherapy in locally advanced hnscc
-
1:41
cems - ecografia - centro medico specialistico verona
-
1:23
evaluating options for hpv oropharyngeal cancer: cisplatin-rt vs. cetuximab-rt
-
28:31
proff.ssa marina frontali - roma 12 dicembre 2015